Risk Management, Ethics, and Compliance Considerations in the New Normal with Myriam Prescott, Head of Ethics, Risks and Compliance – Oncology, Novartis Canada

Myriam Prescott, Head of Ethics, Risks and Compliance - Oncology, Novartis Canada, dissects the importance of effective patient engagement and strong compliance & monitoring programs. We also dive into the legal and ethical considerations around novel digital technologies, patient data ownership, remote trials, and much more.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalMyriam Prescott: https://www.linkedin.com/in/myriam-prescott-3398031a/Novartis Canada: https://www.novartis.ca/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity.Click the social media buttons to share this episode with your network!To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: Home PageLinkedIn: https://www.linkedin.com/company/impetus-digital/Twitter: impetus_digitalYouTube: Impetus Digital